|Slideshows|October 13, 2017

Trait Stages of Diagnosis for Borderline Personality Disorder

Author(s)Peter Fonagy, OBE, FMedSci, FBA, PhD, Chloe Campbell, PhD, Anthony W. Bateman, MA, FRCPsych

The authors describe an alternative model for BPD diagnosis that is dimensional in nature and requires fulfillment of 4 of 7 personality traits.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Podcast: The Complex Psychopharmacology of Personality Disorders. Prioritizing Symptom Management With Michael Gitlin, MD

ByJoseph F. Goldberg, MD,Michael Gitlin, MD

May 22nd 2026

Narcissism: The Need for Conceptual and Diagnostic Clarity

ByChiara Staal, MSc,Mark L. Ruffalo, MSW, DPsa

March 18th 2026

Comparing SSRI Treatment and DBT for Managing Suicidality in Patients With Borderline Personality Disorder

ByLior Hilsenrath, MD,Orrin Chambers, DO,Kaamil Abid, MD,Albert Dickan, MD,Haley Schuster, MD,Mark Mullen, MD,Rajesh R. Tampi, MD, MS, DFAPA, DFAAGP

March 5th 2026

The Psychopharmacology of Personality Disorders: A Conversation With Michael Gitlin, MD

ByJoseph F. Goldberg, MD,Michael Gitlin, MD

January 28th 2026

Strategies for Improved Collaborative Management of Personality Disorders in Correctional Facilities

ByJoel S. Federbush, MD, MS,Allison Genberg, LCSW, CCHP

January 9th 2026

Latest CME

In-Person Event

Southern California Psychiatry Conference

July 10-11, 2026

Register now!

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Video

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Trait Stages of Diagnosis for Borderline Personality Disorder

Related Content

Podcast: The Complex Psychopharmacology of Personality Disorders. Prioritizing Symptom Management With Michael Gitlin, MD

Narcissism: The Need for Conceptual and Diagnostic Clarity

Comparing SSRI Treatment and DBT for Managing Suicidality in Patients With Borderline Personality Disorder

The Psychopharmacology of Personality Disorders: A Conversation With Michael Gitlin, MD

Strategies for Improved Collaborative Management of Personality Disorders in Correctional Facilities

Latest CME

Southern California Psychiatry Conference

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

The Top 10 Misleading Claims About Antidepressants

Positive Phase 3 Data for Centanafadine to Treat Comorbid ADHD and Anxiety

What Does July 4th Mean for Patients? A Psychiatric Perspective on Holiday Vulnerability

Podcast: Deprescribing Insights From an ASCP Panel of Psychiatric Experts

Burnout, Moral Injury, and the Healthcare System: Clinical Reflections on July 4th